ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,667.56
      0.08%
      US Tech 100
      19,264.40
      0.49%
      Dow Jones
      41,985.35
      0.08%
      Brent Oil
      71.485
      -0.50%
      Bitcoin
      85,952.10
      -0.13%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. BGSF Inc (BGSF) Quote

      BGSF Inc

      BGSF Inc (BGSF)

      NYSE
      3.54
      -0.15
      (-4.07%)
      Closed March 23 4:00PM
      Delayed by 15 minutes
      3.54
      0.00
      (0.00%)
      After Hours: 4:25PM
      Delayed by 15 minutes
      Advanced chart

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      3.54
      Bid
      -
      Ask
      -
      Volume
      32,631
      3.40 Day's Range 3.735
      3.34 52 Week Range 10.495
      Market Cap
      39.025M
      Previous Close
      3.69
      Open
      3.70
      Last Trade
      2820
      @
      3.54
      Last Trade Time
      Financial Volume
      $ 115,164
      VWAP
      3.5293
      Average Volume (3m)
      21,247
      Shares Outstanding
      11,024,013
      Dividend Yield
      -
      PE Ratio
      -3.82
      Earnings Per Share (EPS)
      -0.93
      Revenue
      313.17M
      Net Profit
      -10.22M

      About BGSF Inc

      BGSF Inc is engaged in providing temporary staffing services. The company has expertise in Real Estate, Professional, and Light Industrial sectors. The majority of its revenue comes from the Professional segment that provides skilled field talent on a nationwide basis for information technology & fi... BGSF Inc is engaged in providing temporary staffing services. The company has expertise in Real Estate, Professional, and Light Industrial sectors. The majority of its revenue comes from the Professional segment that provides skilled field talent on a nationwide basis for information technology & finance, accounting, legal and human resource client partner projects on a national basis. The services offered by the company include Staffing and Recruiting, Executive Search, Project & Consulting, and Onsite Management. Show more

      Sector
      Help Supply Services
      Industry
      Help Supply Services
      Website
      www.bgsf.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      BGSF Inc is listed in the Help Supply Services sector of the New York Stock Exchange with ticker BGSF. The last closing price for BGSF was $3.69. Over the last year, BGSF shares have traded in a share price range of $ 3.34 to $ 10.495.

      BGSF currently has 11,024,013 shares outstanding. The market capitalization of BGSF is $40.68 million. BGSF has a price to earnings ratio (PE ratio) of -3.82.

      Ask ADVFN Intelligence (AI)

      BGSF Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      March 18 2025
      BGSF (-4.07%)

      Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
      Edgar (US Regulatory)
      February 11 2025
      BGSF (-4.07%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 07 2025
      BGSF (-4.07%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 07 2025
      BGSF (-4.07%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 07 2025
      BGSF (-4.07%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 07 2025
      BGSF (-4.07%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 07 2025
      BGSF (-4.07%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 08 2024
      BGSF (-4.07%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.11-3.013698630143.655.253.34790924.03799556CS
      4-1.39-28.19472616634.935.253.34304464.11933339CS
      12-2.53-41.68039538716.076.23.34212474.68491364CS
      26-3.83-51.96743554957.379.063.34226155.91099356CS
      52-6.71-65.463414634110.2510.4953.34273566.97955648CS
      156-9.94-73.738872403613.4816.0233.34210199.46259301CS
      260-4.91-58.10650887578.4516.913.343712210.79839345CS

      BGSF - Frequently Asked Questions (FAQ)

      What is the current BGSF share price?
      The current share price of BGSF is $ 3.54
      How many BGSF shares are in issue?
      BGSF has 11,024,013 shares in issue
      What is the market cap of BGSF?
      The market capitalisation of BGSF is USD 40.68M
      What is the 1 year trading range for BGSF share price?
      BGSF has traded in the range of $ 3.34 to $ 10.495 during the past year
      What is the PE ratio of BGSF?
      The price to earnings ratio of BGSF is -3.82
      What is the cash to sales ratio of BGSF?
      The cash to sales ratio of BGSF is 0.12
      What is the reporting currency for BGSF?
      BGSF reports financial results in USD
      What is the latest annual turnover for BGSF?
      The latest annual turnover of BGSF is USD 313.17M
      What is the latest annual profit for BGSF?
      The latest annual profit of BGSF is USD -10.22M
      What is the registered address of BGSF?
      The registered address for BGSF is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the BGSF website address?
      The website address for BGSF is www.bgsf.com
      Which industry sector does BGSF operate in?
      BGSF operates in the HELP SUPPLY SERVICES sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALURAllurion Technologies Inc
      $ 3.602
      (57.98%)
      		74.24M
      AMPXAmprius Technologies Inc
      $ 3.105
      (34.42%)
      		11.59M
      TISITeam Inc
      $ 17.35
      (18.75%)
      		33.63k
      KUKEKuke Music Holding Limited
      $ 2.9395
      (17.58%)
      		450.39k
      GTN.AGray Media Inc
      $ 8.55
      (14.61%)
      		5.68k
      NOVASunnova Energy International Inc
      $ 0.4103
      (-22.58%)
      		22.07M
      KLCKindercare Learning Companies Inc
      $ 13.75
      (-22.23%)
      		3.38M
      BEDUBright Scholar Education Holdings Limited
      $ 1.59
      (-16.32%)
      		95.7k
      BODIBeachbody Company Inc
      $ 6.61
      (-14.71%)
      		11.85k
      YSGYatsen Holding Limited
      $ 4.67
      (-13.52%)
      		568.86k
      PFEPfizer Inc
      $ 26.28
      (0.34%)
      		349.99M
      FFord Motor Company
      $ 10.00
      (-0.10%)
      		240.56M
      QBTSD Wave Quantum Inc
      $ 8.355
      (-3.86%)
      		97.4M
      TAT&T Inc
      $ 27.02
      (0.86%)
      		91.27M
      NIONIO Inc
      $ 4.50
      (-4.46%)
      		82.88M

      BGSF Financials

      Financials

      Discussion

      View Full Feed
      dinogreeves dinogreeves 4 minutes ago
      All I can say is be careful what you wish for. AI is very dangerous. You see the comments from MAGA.

      https://www.youtube.com/watch?v=7wkotY0SsO4
      AZRH
      skitahoe skitahoe 4 minutes ago
      GGB,

      I've asked this question before, even if Keytruda is very effective when used with DCVax-L and it's proven in trials, how does that protect Keytruda if generic forms of it are available.

      How does a trial with Keytruda that's successful prevent someone from using D
      NWBO
      Mr. Dragon Mr. Dragon 5 minutes ago
      shyster /shi'st?r/
      noun

      An unethical, unscrupulous practitioner, especially of law. A trickish knave; one who carries on any business, especially legal business, in a mean and dishonest way. Someone who acts in a disreputable, unethical, or unscrupulous way, especially in the p
      DPLS
      3331 3331 5 minutes ago
      BIEL VA HUGE!
      https://veteranrecovery.org/
      FFFacts FFFacts 5 minutes ago
      Huh? Freak.
      HyGro HyGro 6 minutes ago
      Regulators require clinical evidence and other than GBM, NWBO has no other evidence.
      NWBO
      JoeForkeyBolo JoeForkeyBolo 6 minutes ago
      After the full MONI audit report...

      https://i.imgflip.com/9oec3j.gif
      MONI
      blackcat blackcat 7 minutes ago
      Yeah flights were way different then. I can remember flying Paris to Vancouver BC and the captain apologized that the coffee and tea service had to be stopped until the flight cleared some turbulence!
      MrMike241 MrMike241 9 minutes ago
      Bill and Hillary speaches in Berlin at the World Forum 2025 on the Future of Democracy

      https://youtu.be/23la2NKdBHo?si=0ej7fJuzdpjRM97t

      https://youtu.be/_DZ4TdjCmQc?si=5q7V7EjQuEMxICx2
      GoodGuyBill GoodGuyBill 9 minutes ago
      Much ado about nothing....

      This is what I said (as you quoted): "DCVax works, targeting all tumor-based cancers, is highly scalable, and is extensively protected by patents." Is this not true, please explain?!

      DCVax has demonstrated promising results in glioblastoma (n
      NWBO
      Almosthere Almosthere 10 minutes ago
      If the contract comes from the USA through lqmt we are outsourcing to Eontec/yihao same as Evie ring.

      Eontec cannot cancel, modify or ignore. They are being outsourced for the job.

      “Eon (via Yihao) will produce the part under the cost plus contract”

      Get i
      LQMT
      B402 B402 10 minutes ago
      Tell me about it marie....No wonder dems are at 29 and 21%........No wonder they lost, No wonder they are lost in the woods now.........

      Thanks
      wdereb79 wdereb79 10 minutes ago
      Looks like you will be able to get that 7.50 target. Congrats.
      FNMA
      downdraft downdraft 10 minutes ago
      I wonder why CEO’s don’t do back to back smaller reverse splits, so as to not shock the markets, if they really feel the need to have a better share structure or price?

      Given the situation here, with rising share accumulation the past 7 weeks, it wouldn’t bother me if I saw something
      TPTW
      Brodey79 Brodey79 11 minutes ago
      Agree 100%. It shouldn’t come as a surprise to anyone if it happens. They said so themselves in a 2023 release. There is also the possibility of delisting from otc and going ipo route. Anything is possible.
      FDCT
      manibiotech manibiotech 11 minutes ago
      Yep but they are not willing to lend them 50M under non toxic terms , to keep the lights on . Try harder
      NWBO
      Kool Aid Man Kool Aid Man 12 minutes ago
      IMO..Park's latest PR is designed to blunt the reaction when his 2024 annual report drops. It's due on Saturday (90 days after end of fiscal year)..possibly the next business day (Monday the 31st).

      As I read the following PR, Datang is the latest in his list of partners whom he clai
      SPZI
      Mr. Dragon Mr. Dragon 13 minutes ago
      The only review I'm interested in is the margin review.
      NIO
      MrMike241 MrMike241 13 minutes ago
      Jon Ossoff in Atlanta.
      https://youtu.be/sEFzw21cx7Q?si=KIMr-y38BopATH1E
      BlueChip$ BlueChip$ 14 minutes ago
      I mostly agree with that, But they will be advised to do what is needed to uplist and either they do or don't...Getting the sp to what they need is a lot easier with a 5 million float  and much more inviting to Institutional investors vs the current structure. Either way, it is what is.
      FDCT
      Buckey Buckey 14 minutes ago
      Tesla readings
      https://x.com/robinivski/status/1903829152395923708?s=46
      B402 B402 14 minutes ago
      Also fits like a glove with couple posters here, lol.....No congrats , thanks anyway. Fallacies are about the only language spoken here.....Not many honest brokers ;)
      MightyX MightyX 15 minutes ago
      It’s no-wonder TPT joined SAMENA Council for international leverage.
      TPTW
      shoondale shoondale 15 minutes ago
      Medesol Coronacide scam repeats itself at $MGON. Beware!!!!
      https://i.giphy.com/5QMOICVmXremPSa0k7.webp
      MGON
      AAPL31415926 AAPL31415926 16 minutes ago
      Gary don't sell the company short. Merck gets $25 billion per year revenue from Keytruda. I think they'd be happy to pay $25B for Nwbo to extend their patent out another 10 years and prevent anyone else from having this treatment. Not to mention all the patents and Flaskworks. And that would probab
      NWBO

      Your Recent History

      NYSE
      BGSF
      BGSF
      BOV
      PNVL3R
      DIMED ON
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads